| Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program RB Shah, R Mehra, AM Chinnaiyan, R Shen, D Ghosh, M Zhou, ... Cancer research 64 (24), 9209-9216, 2004 | 735 | 2004 |
| Prostate-specific membrane antigen expression as a predictor of prostate cancer progression S Perner, MD Hofer, R Kim, RB Shah, H Li, P Möller, RE Hautmann, ... Human pathology 38 (5), 696-701, 2007 | 567 | 2007 |
| JAGGED1 expression is associated with prostate cancer metastasis and recurrence S Santagata, F Demichelis, A Riva, S Varambally, MD Hofer, JL Kutok, ... Cancer research 64 (19), 6854-6857, 2004 | 439 | 2004 |
| Whole-exome sequencing of metastatic cancer and biomarkers of treatment response H Beltran, K Eng, JM Mosquera, A Sigaras, A Romanel, H Rennert, ... JAMA oncology 1 (4), 466-474, 2015 | 310 | 2015 |
| Decreased α-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death MA Rubin, TA Bismar, O Andrén, L Mucci, R Kim, R Shen, D Ghosh, ... Cancer Epidemiology Biomarkers & Prevention 14 (6), 1424-1432, 2005 | 173 | 2005 |
| Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells CJ Dimitroff, L Descheny, N Trujillo, R Kim, V Nguyen, W Huang, ... Cancer research 65 (13), 5750-5760, 2005 | 153 | 2005 |
| RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease KM Gust, MD Hofer, SR Perner, R Kim, AM Chinnaiyan, S Varambally, ... Neoplasia 11 (9), 956-963, 2009 | 134 | 2009 |
| Defining aggressive prostate cancer using a 12-gene model TA Bismar, F Demichelis, A Riva, R Kim, S Varambally, L He, J Kutok, ... Neoplasia 8 (1), 59-68, 2006 | 127 | 2006 |
| Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase D Di Vizio, RM Adam, J Kim, R Kim, F Sotgia, T Williams, F Demichelis, ... Cell cycle 7 (14), 2257-2267, 2008 | 109 | 2008 |
| Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care H Rennert, K Eng, T Zhang, A Tan, J Xiang, A Romanel, R Kim, W Tam, ... NPJ genomic medicine 1 (1), 1-11, 2016 | 81 | 2016 |
| Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer KD Mertz, F Demichelis, R Kim, P Schraml, M Storz, PA Diener, H Moch, ... Human pathology 38 (10), 1454-1462, 2007 | 68 | 2007 |
| Characterization of ZAG protein expression in prostate cancer using a semi‐automated microscope system A Descazeaud, A De La Taille, Y Allory, H Faucon, L Salomon, T Bismar, ... The Prostate 66 (10), 1037-1043, 2006 | 54 | 2006 |
| Next-generation rapid autopsies enable tumor evolution tracking and generation of preclinical models DJ Pisapia, S Salvatore, C Pauli, E Hissong, K Eng, D Prandi, VW Sailer, ... JCO precision oncology 1, 1-13, 2017 | 53 | 2017 |
| Bone biopsy protocol for advanced prostate cancer in the era of precision medicine V Sailer, MH Schiffman, M Kossai, J Cyrta, S Beg, B Sullivan, BB Pua, ... Cancer 124 (5), 1008-1015, 2018 | 52 | 2018 |
| Integrative molecular analysis of patients with advanced and metastatic cancer V Sailer, KW Eng, T Zhang, R Bareja, DJ Pisapia, A Sigaras, B Bhinder, ... JCO precision oncology 3, 1-12, 2019 | 41 | 2019 |
| Prostate cancer with Paneth cell–like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification K Park, Z Chen, TY MacDonald, J Siddiqui, H Ye, A Erbersdobler, ... Human pathology 45 (10), 2136-2143, 2014 | 36 | 2014 |
| Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium R Esgueva, K Park, R Kim, N Kitabayashi, CE Barbieri, PJ Dorsey Jr, ... Diagnostic Molecular Pathology 21 (2), 61-68, 2012 | 34 | 2012 |
| Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort LA Mucci, Y Pawitan, F Demichelis, K Fall, JR Stark, HO Adami, ... Cancer Epidemiology Biomarkers & Prevention 17 (7), 1682-1688, 2008 | 28 | 2008 |
| Functional comparison of exome capture-based methods for transcriptomic profiling of formalin-fixed paraffin-embedded tumors KS Shohdy, R Bareja, M Sigouros, DC Wilkes, P Dorsaint, J Manohar, ... NPJ Genomic Medicine 6 (1), 66, 2021 | 13 | 2021 |
| Internet-based Profiler system as integrative framework to support translational research R Kim, F Demichelis, J Tang, A Riva, R Shen, DF Gibbs, V Mahavishno, ... BMC bioinformatics 6, 1-11, 2005 | 12 | 2005 |
